135 related articles for article (PubMed ID: 34619865)
21. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.
Hong MK; Laskin WB; Herman BE; Johnston MH; Vargo JJ; Steinberg SM; Allegra CJ; Johnston PG
Cancer; 1995 Jan; 75(2):423-9. PubMed ID: 7812911
[TBL] [Abstract][Full Text] [Related]
22. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
Lam KY; Law S; Tin L; Tung PH; Wong J
Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kajiwara H; Tsuchida T; Tanaka M; Tajima T; Makuuchi H
Anticancer Res; 2000; 20(5C):3717-22. PubMed ID: 11268444
[TBL] [Abstract][Full Text] [Related]
24. [Pediatric pancreatic lesions: a clinicopathological analysis of 42 cases].
Gao Q; Xu H; Wang FH; Yi P; Yang TY; Li LP; Xia JQ; Zeng RX; Niu HL
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):861-867. PubMed ID: 36097903
[No Abstract] [Full Text] [Related]
25. Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.
Shimizu Y; Yoshida T; Kato M; Hirota J; Ono S; Nakagawa M; Kobayashi T; Kubota K; Asaka M
J Gastroenterol Hepatol; 2010 Feb; 25(2):314-8. PubMed ID: 19968747
[TBL] [Abstract][Full Text] [Related]
26. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China.
Dawsey SM; Fleischer DE; Wang GQ; Zhou B; Kidwell JA; Lu N; Lewin KJ; Roth MJ; Tio TL; Taylor PR
Cancer; 1998 Jul; 83(2):220-31. PubMed ID: 9669803
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiles of esophageal cancer.
Feber A; Xi L; Luketich JD; Pennathur A; Landreneau RJ; Wu M; Swanson SJ; Godfrey TE; Litle VR
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):255-60; discussion 260. PubMed ID: 18242245
[TBL] [Abstract][Full Text] [Related]
28. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases.
Ohashi K; Horiguchi S; Moriyama S; Hishima T; Hayashi Y; Momma K; Hanashi T; Izumi Y; Yoshida M; Funata N
Pathol Res Pract; 2003; 199(11):713-21. PubMed ID: 14708637
[TBL] [Abstract][Full Text] [Related]
29. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China.
Dawsey SM; Lewin KJ; Wang GQ; Liu FS; Nieberg RK; Yu Y; Li JY; Blot WJ; Li B; Taylor PR
Cancer; 1994 Sep; 74(6):1686-92. PubMed ID: 8082069
[TBL] [Abstract][Full Text] [Related]
30. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
31. Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus.
Kuwano H; Watanabe M; Sadanaga N; Ikebe M; Mori M; Sugimachi K
Cancer Lett; 1993 Aug; 72(3):141-7. PubMed ID: 8402583
[TBL] [Abstract][Full Text] [Related]
32. Histological classification of intraepithelial neoplasias and microinvasive squamous carcinoma of the esophagus.
Rubio CA; Liu FS; Zhao HZ
Am J Surg Pathol; 1989 Aug; 13(8):685-90. PubMed ID: 2751041
[TBL] [Abstract][Full Text] [Related]
33. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
34. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
35. High-grade dysplasia, restricted to the basal cell layer involving the entire esophagus.
Sarbia M; Wolfer S; Karimi D; Eimiller A
World J Gastroenterol; 2015 Feb; 21(5):1663-5. PubMed ID: 25663787
[TBL] [Abstract][Full Text] [Related]
36. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
[TBL] [Abstract][Full Text] [Related]
37. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Feith M; Stein HJ; Mueller J; Siewert JR
Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
[TBL] [Abstract][Full Text] [Related]
39. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
Wang F; Xie XJ; Piao YS; Liu B; Wang LD
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
[TBL] [Abstract][Full Text] [Related]
40. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
